SERENDIP HOLDINGS Co.,Ltd. Logo

SERENDIP HOLDINGS Co.,Ltd.

Consulting & investment firm aiding manufacturing SMEs with M&A, succession, and revitalization.

7318 | T

Overview

Corporate Details

ISIN(s):
JP3423750003
LEI:
Country:
Japan
Address:
名古屋市中区錦一丁目5番11号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

SERENDIP HOLDINGS Co., Ltd. is a business consulting and investment firm dedicated to supporting the growth and modernization of small and medium-sized enterprises (SMEs), with a particular focus on the manufacturing sector. The company provides a comprehensive suite of services including M&A advisory, business succession support, management consulting, corporate revitalization, and the dispatch of professional managers. By integrating M&A solutions with the placement of experienced executives, Serendip Holdings addresses critical challenges such as leadership succession and operational improvement. The firm's core mission is to foster the creation of sustainable "100-year companies" by modernizing their management and ensuring their adaptability to new technologies and evolving market structures.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-12 07:21
Registration Form
確認書
Japanese 8.3 KB
2025-11-12 07:21
Interim Report
半期報告書-第21期(2025/04/01-2026/03/31)
Japanese 259.6 KB
2025-07-01 08:30
Registration Form
有価証券届出書(組込方式)
Japanese 130.9 KB
2025-06-26 09:06
Post-Annual General Meeting Information
臨時報告書
Japanese 24.4 KB
2025-06-24 08:48
Registration Form
確認書
Japanese 8.2 KB
2025-06-24 08:47
Governance Information
内部統制報告書-第20期(2024/04/01-2025/03/31)
Japanese 22.7 KB
2025-06-24 08:46
Annual Report
有価証券報告書-第20期(2024/04/01-2025/03/31)
Japanese 1.3 MB
2025-05-14 03:18
M&A Activity
臨時報告書
Japanese 39.7 KB
2024-12-27 03:22
Capital/Financing Update
臨時報告書
Japanese 19.9 KB
2024-11-12 07:02
Report Publication Announcement
確認書
Japanese 8.2 KB
2024-11-12 06:58
Interim Report
半期報告書-第20期(2024/04/01-2025/03/31)
Japanese 243.6 KB
2024-10-25 07:41
Regulatory News Service
臨時報告書
Japanese 43.6 KB
2024-07-02 09:43
Post-Annual General Meeting Information
臨時報告書
Japanese 28.4 KB
2024-06-28 08:38
Registration Form
確認書
Japanese 8.2 KB
2024-06-28 08:37
Governance Information
内部統制報告書-第19期(2023/04/01-2024/03/31)
Japanese 22.4 KB

Automate Your Workflow. Get a real-time feed of all SERENDIP HOLDINGS Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SERENDIP HOLDINGS Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SERENDIP HOLDINGS Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.